IGF-I H RECOMBINANT (500)
Home Up IL-2 § RECOMBINANT IL-6 § RECOMBINANT EGF human RECOMBINANT EGF human RECOMBINANT EGF human RECOMBINANT NGF mouse natural NGF mouse natural NGF mouse natural FGF 2 H RECOMBINANT(10) FGF 2 H RECOMBINANT (100) AFGF 1 H RECOMBINANT (10) AFGF 1 H RECOMBINANT (50) IGF-I H  RECOMBINANT (50) IGF-I H RECOMBINANT (500) Human IGF-II RECOMBINANT H IGF-II RECOMBINANT (500) PDGF-BB H RECOMBINANT PDGF-BB human RECOMBINANT PDGF-BB hu RECOMBINANT PDGF-AA hum RECOMBINANT PDGF-AA huma RECOMBINANT TNF alpha H RECOMBINANT TNF alpha huma RECOMBINANT HTGF beta-1 recombinant HTGF - beta-2 recombinant Human recombinant nerve NGF M-CSF H RECOMBINANT M-CSF human RECo beta Interferon H RECOMBINANT H SOD RECO (SOD) (RECOMBINANT) mouse GM-CSF

 

 

Product Details: Insulin-like Growth Factor (IGF-I) human (RECOMBINANT)

Basic Information

 


Product ID: GF-050-8
Product Name: Insulin-like Growth Factor (IGF-I) human (RECOMBINANT)
Unit: 500µg
Price: 365 Euro
Availability: Available
Category: Growth Factors, Cytokines, Receptors and their Antibodies
Subcategory: Growth Factors/Cytokines/Enzymes

 

Product Details

 


Description: Human IGF-I is a potent mitogen for mesenchymally-derived cells. It is composed of 70 amino acid residues, and is 62% homologous with human IGF-II.

Human IGF-I is produced by genetically engineered yeast, and purified by sequential chromatography.

 

Molecular Weight: 7.5 KDa
Biological Activity: The material is active in a receptor-binding assay using a membrane preparation from placenta.

 

Formulation: Lyophilized powder
Purity: Over 95% pure by N-terminal amino acid sequencing, amino acid composition, HPLC analysis, and SDS gel electrophoresis.
Storage Conditions: Store at +4°C. Reconstitution is best in water or buffer near neutral pH. After reconstitution, storage in aliquots at -80°C is recommended.
Stability: Several months, lyophilized or in solution, at pH 6-7 and +4°C.
Temperature: +4°C
References: 1. Modern Concepts of Insulin-Like Growth Factor. Ed. E. Martin Spencer, M.D. (1991). Elsevier Science Publ. (New York).
2 D'Ercole, A.J. (1987) J. Dev. Physiol. 9:481-495
3. Daughaday, W.H. and Rotwein, P. (1989) Endocr. Rev. 10:68-91